Bausch & Lomb (BLCO) Other Non-Current Assets (2021 - 2026)
Bausch & Lomb (BLCO) reported Other Non-Current Assets of $302.0 million for Q1 2026, up 2.37% on a YoY basis from $295.0 million in Q1 2025, and down 2.58% quarter-over-quarter from $310.0 million in Q4 2025.
Bausch & Lomb (BLCO) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported Other Non-Current Assets for 6 years, with the latest figure at $302.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 2.37% year-over-year to $302.0 million; the trailing twelve-month figure through Mar 2026 stood at $302.0 million (up 2.37% YoY), and the FY2025 full-year result was $310.0 million, up 5.44% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $302.0 million, down from $310.0 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $310.0 million in Q3 2024, with the low at $188.0 million in Q1 2022.
- Historically, Other Non-Current Assets has averaged $253.5 million across 5 years, with a median of $231.0 million in 2024.
- Annual changes were most pronounced in 2023 — Other Non-Current Assets dropped 7.02% — and 2024, when it soared 46.23%.
- Bausch & Lomb's Other Non-Current Assets stood at $215.0 million in 2022, then grew by 4.65% to $225.0 million in 2023, then surged by 30.67% to $294.0 million in 2024, then rose by 5.44% to $310.0 million in 2025, then dropped by 2.58% to $302.0 million in 2026.
- The last three Other Non-Current Assets figures came in at $302.0 million (Q1 2026), $310.0 million (Q4 2025), and $303.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 2.43 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 446.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 210.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 81.30 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 848.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 39.83 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 692.00 Mn |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn | 302.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 302.00 Mn |
| Dec 31, 2025 | 310.00 Mn |
| Sep 30, 2025 | 303.00 Mn |
| Jun 30, 2025 | 305.00 Mn |
| Mar 31, 2025 | 295.00 Mn |
| Dec 31, 2024 | 294.00 Mn |
| Sep 30, 2024 | 310.00 Mn |
| Jun 30, 2024 | 249.00 Mn |
| Mar 31, 2024 | 231.00 Mn |
| Dec 31, 2023 | 225.00 Mn |
| Sep 30, 2023 | 212.00 Mn |
| Jun 30, 2023 | 207.00 Mn |
| Mar 31, 2023 | 213.00 Mn |
| Dec 31, 2022 | 215.00 Mn |
| Sep 30, 2022 | 228.00 Mn |
| Jun 30, 2022 | 222.00 Mn |
| Mar 31, 2022 | 188.00 Mn |
| Dec 31, 2021 | 180.00 Mn |